Please use this identifier to cite or link to this item:
|Title:||Pharmacist-led CYP2C19 genotyping in patients on clopidogrel therapy following percutaneous coronary intervention|
Xuereb, Robert G.
Azzopardi, Lilian M.
Coronary heart disease -- Chemotherapy -- Malta
Pharmacogenetics -- Malta
Coronary arteries -- Stenosis -- Prevention
|Publisher:||University of Malta. Department of Pharmacy|
|Citation:||Wirth, F., Zahra, G., Xuereb, R. G., Barbara, C., Fenech, A., & Azzopardi, L. M. (2015, June). Pharmacist-led CYP2C19 genotyping in patients on clopidogrel therapy following percutaneous coronary intervention. Poster session presented at the Nordic Social Pharmacy and Health Services Research Conference & The Nordic Networking Group for Clinical Pharmacy, Tartu, Estonia.|
|Abstract:||A poster presentation regarding pharmacist-led CYP2C19 genotyping in patients on clopidogrel therapy following percutaneous coronary intervention. Background: CYP2C19, a cytochrome P450 enzyme encoded by a highly polymorphic gene, is involved in the metabolism of clinically important drugs such as clopidogrel. The 2013 Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for CYP2C19 genotype and clopidogrel therapy, classify CYP2C19 genotypes into 4 groups according to metaboliser status in relation to clopidogrel: ‘Extensive metabolisers’, carrying only normal function alleles (EMs *1/*1), ‘ultra-rapid metabolisers’, carrying at least one gain-of-function (GoF) allele (UMs *1/*17, *17/*17), ‘intermediate metabolisers’, carrying one loss-of-function (LoF) allele (IMs *1/*2, *2/*17), and ‘poor metabolisers’, carrying two LoF alleles (PMs *2/*2). Objective: To implement a laboratory-based, pharmacist-led process to genotype patients who were prescribed clopidogrel therapy post-percutaneous coronary intervention (PCI) for the CYP2C19 LoF (*2) and GoF (*17) variant alleles.|
|Appears in Collections:||Scholarly Works - FacM&SPha|
Files in This Item:
|Pharmacist_led_CYP2C19_genotyping_in_patients_on_clopidogrel_therapy_following_percutaneous _coronary_intervention_2015.pdf||576.54 kB||Adobe PDF||View/Open|
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.